All the news Showing 6 of 36 articles from: Treatment in liver transplantedGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources European Medicines Agency advises on compassionate use of sofosbuvir European Medicines Agency / 26 October 2013 Sofosbuvir and daclatasvir: compassionate use in liver transplant patient with HCV Detroit News / 17 September 2013 Patients with recurrent HCV benefit from triple therapy after liver transplant Healio Hepatology / 17 September 2013 Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common Liz Highleyman / 17 May 2013 Adding the approved HCV protease inhibitor telaprevir (Incivo or Incivek) to pegylated interferon and ribavirin can increase sustained response rates even for difficult-to-treat liver transplant recipients, but adverse events are common, researchers reported at ... Drug Trio Helps Treat HCV After Transplant MedPage Today Gastroenterology / 30 April 2013 Milk Thistle Drug May Help Control HCV Replication after Liver Transplant HIVandhepatitis.com / 02 March 2013 ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive